Related Experiment Video
Updated: Jul 26, 2026

Microinjection Method for Anopheles gambiae Embryos
Published on: July 7, 2021
Recent advances in transmission-blocking drugs for malaria elimination
Ishan Wadi1,2, Mahendra Nath2, Anupkumar R Anvikar1
1ICMR-National Institute of Malaria Research, Dwarka, New Delhi 110077, India.
Abstract:
The scientific community worldwide has realized that malaria elimination will not be possible without development of safe and effective transmission-blocking interventions. Primaquine, the only WHO recommended transmission-blocking drug, is not extensively utilized because of the toxicity issues in G6PD deficient individuals. Therefore, there is an urgent need to develop novel therapeutic interventions that can target malaria parasites and effectively block transmission. But at first, it is imperative to unravel the existing portfolio of transmission-blocking drugs. This review highlights transmission-blocking potential of current antimalarial drugs and drugs that are in various stages of clinical development. The collective analysis of the relationships between the structure and the activity of transmission-blocking drugs is expected to help in the design of new transmission-blocking antimalarials.
Related Concept Videos
Malaria
Anthelminthic Agents
Antiprotozoal Agents

